Genetic polymorphisms of p53 and GSTP1,but not NAT2,are associated with susceptibility to squamous‐cell carcinoma of the esophagus

The interaction of genetic and environmental factors can determine an individual's susceptibility to various cancers. We present a hospital‐based case‐control study, which included 90 patients of esophageal squamous‐cell carcinoma (ESCC) and 254 healthy people in Taiwan, to investigate the effects of genetic polymorphisms of p53, GSTP1 and NAT2 on the risk of ESCC. Polymorphisms of p53, NAT2 and GSTP1 were determined by PCR‐RFLP. The codon 72 p53 Pro allele was more frequently found in ESCC patients [odds ratio (OR) 1.86, 95% confidence interval (CI) 1.04–3.35 for Arg/Pro genotype and OR 2.56, 95% CI 1.29–5.08 for Pro/Pro genotype]. In cigarette smokers, the frequency of GSTP1 Ile/Ile genotype was higher in ESCC patients (OR 2.8, 95% CI 1.4–5.7). Among alcohol drinkers, borderline significance was also found for GSTP1 Ile/Ile genotype (OR 2.0, 95% CI 0.9–4.4). Results were not similar for the NAT2 genetic polymorphism. Using logistic analyses, we found that individuals with p53 Pro/Pro genotype had a significantly higher risk of developing ESCC than those with Arg/Arg genotype (OR 2.3, 95% CI 1.1–5.1), after adjusting for other significant environmental risk factors. This result remained similar (OR 2.2, 95% CI 1.0–4.8 for p53 Pro/Pro vs. Arg/Arg), even after further adjustment for NAT2 and GSTP1 polymorphisms. The codon 72 p53 Pro/Pro genotype in the general population and GSTP1 Ile/Ile in cigarette smokers may predict a higher risk of developing ESCC. Int. J. Cancer 89:458–464, 2000. © 2000 Wiley‐Liss, Inc.

[1]  C. Meijer,et al.  Analysis of human papillomavirus type 16 E6 variants in relation to p53 codon 72 polymorphism genotypes in cervical carcinogenesis. , 2000, The Journal of general virology.

[2]  A. Giannoudis,et al.  p53 codon 72 ARG/PRO polymorphism is not related to HPV type or lesion grade in low‐ and high‐grade squamous intra‐epithelial lesions and invasive squamous carcinoma of the cervix , 1999, International journal of cancer.

[3]  J. V. van Lanschot,et al.  Barrett esophagus and cancer: pathogenesis, carcinogenesis, and diagnostic dilemmas. , 1999, Histology and histopathology.

[4]  M. Spitz,et al.  Glutathione‐S‐transferase polymorphisms and risk of squamous‐cell carcinoma of the head and neck , 1999, International journal of cancer.

[5]  P. Dayer,et al.  Glutathione S‐transferase GSTM1, GSTM3, GSTP1 and GSTT1 genotypes and the risk of smoking‐related oral and pharyngeal cancers , 1999, International journal of cancer.

[6]  C. J. Chen,et al.  Ap53genetic polymorphism as a modulator of hepatocellular carcinoma risk in relation to chronic liver disease, familial tendency, and cigarette smoking in hepatitis B carriers , 1999, Hepatology.

[7]  Miranda Thomas,et al.  Two Polymorphic Variants of Wild-Type p53 Differ Biochemically and Biologically , 1999, Molecular and Cellular Biology.

[8]  T. Wobbes,et al.  Polymorphic expression of the glutathione S-transferase P1 gene and its susceptibility to Barrett's esophagus and esophageal carcinoma. , 1999, Cancer research.

[9]  A. Hirvonen.  Polymorphic NATs and cancer predisposition. , 1999, IARC scientific publications.

[10]  P. Lin,et al.  p53 codon 72 polymorphism in Taiwanese lung cancer patients: association with lung cancer susceptibility and prognosis. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[11]  Y. Doki,et al.  Association between genetic polymorphisms of glutathione S‐transferase P1 and N‐acetyltransferase 2 and susceptibility to squamous‐cell carcinoma of the esophagus , 1998, International journal of cancer.

[12]  I. Jacobs,et al.  p53 codon 72 polymorphism and risk of cervical cancer in UK , 1998, The Lancet.

[13]  Irene M. Leigh,et al.  Role of a p53 polymorphism in the development of human papilloma-virus-associated cancer , 1998, Nature.

[14]  G. B. Smith,et al.  Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution. , 1998, Carcinogenesis.

[15]  P. Dayer,et al.  Larynx cancer risk in relation to glutathione S-transferase M1 and T1 genotypes and tobacco smoking. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[16]  S. Srivastava,et al.  Mechanism of differential catalytic efficiency of two polymorphic forms of human glutathione S-transferase P1-1 in the glutathione conjugation of carcinogenic diol epoxide of chrysene. , 1997, Archives of biochemistry and biophysics.

[17]  G. Prendergast,et al.  The polyproline region of p53 is required to activate apoptosis but not growth arrest , 1997, Oncogene.

[18]  A. Risch,et al.  Mapping AAC1, AAC2 and AACP, the genes for arylamine N-acetyltransferases, carcinogen metabolising enzymes on human chromosome 8p22, a region frequently deleted in tumours. , 1997, Cytogenetics and cell genetics.

[19]  L. Harries,et al.  Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. , 1997, Carcinogenesis.

[20]  J. Buolamwini,et al.  Molecular Cloning, Characterization, and Expression in Escherichia coli of Full-length cDNAs of Three Human Glutathione S-Transferase Pi Gene Variants , 1997, The Journal of Biological Chemistry.

[21]  D. Forman,et al.  Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. , 1997, Carcinogenesis.

[22]  S. Tsuchida,et al.  Correlated Expression of Glutathione S‐Transferase‐π and c‐Jun or Other Oncogene Products in Human Squamous Cell Carcinomas of the Head and Neck: Relevance to Relapse after Radiation Therapy , 1997, Japanese journal of cancer research : Gann.

[23]  J. Brockmöller,et al.  Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk. , 1996, Cancer research.

[24]  H. Vainio,et al.  CARCINOGENESIS: Expression of cytochrome P450s and glutathione S-transferases in human esophagus with squamous-cell carcinomas , 1996 .

[25]  G. Hallmans,et al.  p53 polymorphisms and haplotypes in breast cancer. , 1996, Carcinogenesis.

[26]  M. Tagawa,et al.  Analysis of a germ line polymorphism of the p53 gene in lung cancer patients; discrete results with smoking history. , 1996, Carcinogenesis.

[27]  H. Vainio,et al.  Expression of cytochrome P450s and glutathione S-transferases in human esophagus with squamous-cell carcinomas. , 1996, Carcinogenesis.

[28]  R. Benamouzig,et al.  Absence of human papillomavirus DNA detected by polymerase chain reaction in French patients with esophageal carcinoma. , 1995, Gastroenterology.

[29]  C. Smith,et al.  Polymorphisms in drug-metabolizing enzymes as modifiers of cancer risk. , 1995, Clinical chemistry.

[30]  Y. Ko,et al.  Betel quid chewing, cigarette smoking and alcohol consumption related to oral cancer in Taiwan. , 1995, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[31]  M. Spitz,et al.  Higher lung cancer risk for younger African-Americans with the Pro/Pro p53 genotype. , 1995, Carcinogenesis.

[32]  N. Day,et al.  Oesophageal cancer in never‐smokers and never‐drinkers , 1995, International journal of cancer.

[33]  P. Jeffrey,et al.  Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. , 1994, Science.

[34]  A. Rustgi,et al.  Human papillomavirus DNA sequences in esophagus squamous cell carcinoma. , 1994, Gastroenterology.

[35]  Jinfu Hu,et al.  Risk factors for oesophageal cancer in northeast China , 1994, International journal of cancer.

[36]  B. Mannervik,et al.  Detoxication of base propenals and other alpha, beta-unsaturated aldehyde products of radical reactions and lipid peroxidation by human glutathione transferases. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[37]  S. Syrjänen,et al.  Screening for human papillomavirus infections in esophageal squamous cell carcinomas by in situ hybridization , 1993, Cancer.

[38]  Jack A. Taylor,et al.  Genotype/phenotype discordance for human arylamine N-acetyltransferase (NAT2) reveals a new slow-acetylator allele common in African-Americans. , 1993, Carcinogenesis.

[39]  T C Campbell,et al.  Geographic association between urinary excretion of N‐nitroso compounds and oesophageal cancer mortality in china , 1993, International journal of cancer.

[40]  K. Nakachi,et al.  Germ line polymorphisms of p53 and CYP1A1 genes involved in human lung cancer. , 1993, Carcinogenesis.

[41]  R. Rylander,et al.  Genetic polymorphism of cytochrome P4502E1 in a Swedish population , 1993, FEBS letters.

[42]  D. Hopwood,et al.  Abnormal expression of growth regulatory factors in Barrett's oesophagus. , 1991, Clinical science.

[43]  N. Day,et al.  Risk factors for cancer of the oesophagus in Kerala, India , 1991, International journal of cancer.

[44]  B. Vogelstein,et al.  p53 mutations in human cancers. , 1991, Science.

[45]  D. Grant,et al.  Molecular mechanism of slow acetylation of drugs and carcinogens in humans. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[46]  A. Kurosky,et al.  Primary and secondary structural analyses of glutathione S-transferase π from human placenta , 1990 .

[47]  K. Nakachi,et al.  Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P45 0IA1 gene , 1990, FEBS letters.

[48]  R. R. Smith,et al.  Prevalence and characteristics of Barrett esophagus in patients with adenocarcinoma of the esophagus or esophagogastric junction. , 1988, Human pathology.

[49]  T. Mack,et al.  Tobacco, alcohol, diet, occupation, and carcinoma of the esophagus. , 1988, Cancer research.

[50]  K. Ilett,et al.  Acetylation phenotype in colorectal carcinoma. , 1987, Cancer research.

[51]  D. Pim,et al.  Primary structure polymorphism at amino acid residue 72 of human p53 , 1987, Molecular and cellular biology.

[52]  D. Schottenfeld.  Epidemiology of cancer of the esophagus. , 1984, Seminars in oncology.

[53]  S. Lu,et al.  Recent research on the etiology of esophageal cancer in China. , 1982, Zeitschrift fur Gastroenterologie.

[54]  C. S. Yang,et al.  Research on esophageal cancer in China: a review. , 1980, Cancer research.